Literature DB >> 23019123

ELAV mediates 3' UTR extension in the Drosophila nervous system.

Valérie Hilgers1, Sandra B Lemke, Michael Levine.   

Abstract

Post-transcriptional gene regulation is prevalent in the nervous system, where multiple tiers of regulatory complexity contribute to the development and function of highly specialized cell types. Whole-genome studies in Drosophila have identified several hundred genes containing long 3' extensions in neural tissues. We show that ELAV (embryonic-lethal abnormal visual system) is a key mediator of these neural-specific extensions. Misexpression of ELAV results in the ectopic synthesis of long messenger RNAs (mRNAs) in transgenic embryos. RNA immunoprecipitation assays suggest that ELAV directly binds the proximal polyadenylation signals of many target mRNAs. Finally, ELAV is sufficient to suppress 3' end formation at a strong polyadenylation signal when tethered to a synthetic RNA. We propose that this mechanism for coordinating 3' UTR extension may be generally used in a variety of cellular processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019123      PMCID: PMC3475798          DOI: 10.1101/gad.199653.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  34 in total

1.  A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing.

Authors:  Jan Rehwinkel; Isabelle Behm-Ansmant; David Gatfield; Elisa Izaurralde
Journal:  RNA       Date:  2005-09-21       Impact factor: 4.942

2.  The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation.

Authors:  Y Takagaki; R L Seipelt; M L Peterson; J L Manley
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

3.  Developmental and physiological analysis of a conditional mutation affecting photoreceptor and optic lobe development in Drosophila melanogaster.

Authors:  T Homyk; K Isono; W L Pak
Journal:  J Neurogenet       Date:  1985-11       Impact factor: 1.250

4.  Neural-specific carbohydrate moiety shared by many surface glycoproteins in Drosophila and grasshopper embryos.

Authors:  P M Snow; N H Patel; A L Harrelson; C S Goodman
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

5.  The commonly used marker ELAV is transiently expressed in neuroblasts and glial cells in the Drosophila embryonic CNS.

Authors:  Christian Berger; Simone Renner; Karin Lüer; Gerhard M Technau
Journal:  Dev Dyn       Date:  2007-12       Impact factor: 3.780

Review 6.  Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans.

Authors:  K M Yao; M L Samson; R Reeves; K White
Journal:  J Neurobiol       Date:  1993-06

7.  Evidence for 3' untranslated region-dependent autoregulation of the Drosophila gene encoding the neuronal nuclear RNA-binding protein ELAV.

Authors:  M L Samson
Journal:  Genetics       Date:  1998-10       Impact factor: 4.562

8.  Shared RNA-binding sites for interacting members of the Drosophila ELAV family of neuronal proteins.

Authors:  Claudia D Borgeson; Marie-Laure Samson
Journal:  Nucleic Acids Res       Date:  2005-11-10       Impact factor: 16.971

9.  Biased alternative polyadenylation in human tissues.

Authors:  Haibo Zhang; Ju Youn Lee; Bin Tian
Journal:  Genome Biol       Date:  2005-11-28       Impact factor: 13.583

10.  A large-scale analysis of mRNA polyadenylation of human and mouse genes.

Authors:  Bin Tian; Jun Hu; Haibo Zhang; Carol S Lutz
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

View more
  49 in total

1.  Tissue-specific regulation of alternative polyadenylation represses expression of a neuronal ankyrin isoform in C. elegans epidermal development.

Authors:  Fei Chen; Andrew D Chisholm; Yishi Jin
Journal:  Development       Date:  2017-01-13       Impact factor: 6.868

Review 2.  Alternative cleavage and polyadenylation: extent, regulation and function.

Authors:  Ran Elkon; Alejandro P Ugalde; Reuven Agami
Journal:  Nat Rev Genet       Date:  2013-07       Impact factor: 53.242

Review 3.  Alternative polyadenylation coupled to transcription initiation: Insights from ELAV-mediated 3' UTR extension.

Authors:  Valérie Hilgers
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

4.  Genetic variants regulating expression levels and isoform diversity during embryogenesis.

Authors:  Enrico Cannavò; Nils Koelling; Dermot Harnett; David Garfield; Francesco P Casale; Lucia Ciglar; Hilary E Gustafson; Rebecca R Viales; Raquel Marco-Ferreres; Jacob F Degner; Bingqing Zhao; Oliver Stegle; Ewan Birney; Eileen E M Furlong
Journal:  Nature       Date:  2016-12-26       Impact factor: 49.962

5.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

Review 6.  Alternative polyadenylation in the nervous system: to what lengths will 3' UTR extensions take us?

Authors:  Pedro Miura; Piero Sanfilippo; Sol Shenker; Eric C Lai
Journal:  Bioessays       Date:  2014-06-05       Impact factor: 4.345

7.  Widespread Translational Remodeling during Human Neuronal Differentiation.

Authors:  John D Blair; Dirk Hockemeyer; Jennifer A Doudna; Helen S Bateup; Stephen N Floor
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

Review 8.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

9.  Driving glioblastoma growth by alternative polyadenylation.

Authors:  Ting Han; John K Kim
Journal:  Cell Res       Date:  2014-07-04       Impact factor: 25.617

Review 10.  RNA binding proteins: a common denominator of neuronal function and dysfunction.

Authors:  Epaminondas Doxakis
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.